# APOLLO ENDOSURGERY US INC: Form D filings

APOLLO ENDOSURGERY US INC, a biotechnology company in Austin, TX, filed 5 Form D notices with the SEC between 2009 and 2017. The latest, on January 11, 2017, reports $54.4 million sold of a $54.4 million offering to 15 investors.

Find out what APOLLO ENDOSURGERY US INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20APOLLO%20ENDOSURGERY%20US%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=APOLLO%20ENDOSURGERY%20US%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fapollo-endosurgery-us-inc-1369432)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20APOLLO%20ENDOSURGERY%20US%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=APOLLO%20ENDOSURGERY%20US%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fapollo-endosurgery-us-inc-1369432)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Texas](https://specstream.ai/data/form-d/state/texas): 4,800 rows, by operating companies, filed since November 1, 2024, $128, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/texas
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1120 SOUTH CAPITAL OF TX HWY, BUILDING 1 SUITE 300, Austin, TX, 78746
- Phone: (512) 279-5100
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1369432

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 11, 2017 | New notice | $54,432,580 | $54,432,580 | $0 | 15 | Dec 29, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1369432/000136943217000001/0001369432-17-000001-index.htm) |
| Dec 16, 2013 | New notice | $63,727,392 | $60,727,392 | $3,000,000 | 11 | Dec 2, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1369432/000136943213000003/0001369432-13-000003-index.htm) |
| Jul 3, 2013 | New notice | $11,603,494 | $5,044,998 | $6,558,496 | 8 | Jun 18, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1369432/000136943213000001/0001369432-13-000001-index.htm) |
| Feb 10, 2012 | New notice | $53,835,471 | $52,724,242 | $1,111,229 | 14 | Oct 25, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1369432/000136943212000001/0001369432-12-000001-index.htm) |
| Mar 23, 2009 | New notice | $3,166,170 | $3,000,000 | $166,170 | 2 | Mar 6, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1369432/000136943209000003/0001369432-09-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Bruce Robertson, Ph.D. | Director |  |
| Richard Meelia | Director |  |
| John Creecy | Director |  |
| William McClellan, Jr. | Director |  |
| Matthew Crawford | Director |  |
| Charles Tribie | Executive Officer |  |
| Todd Newton | Executive Officer, Director |  |
| Stefanie Cavanaugh | Executive Officer |  |
| R. Kent McGaughy, Jr. | Director |  |
| Bret Schwartzhoff | Executive Officer |  |
| Jack Nielsen | Director |  |
| Rick Anderson | Director |  |
| Dennis McWilliams | Executive Officer |  |

## Other biotechnology companies in Texas that filed recently

- [Nuclein, LLC](https://specstream.ai/data/form-d/company/nuclein-llc-1787352) $15.7 million · Oct 27, 2026
- [OncoNano Medicine, Inc.](https://specstream.ai/data/form-d/company/onconano-medicine-inc-1735726) $10.1 million · Oct 8, 2026
- [Solaris Endovascular Inc.](https://specstream.ai/data/form-d/company/solaris-endovascular-inc-2156481) $5 million · Oct 1, 2026
- [Hera Biotech, Inc.](https://specstream.ai/data/form-d/company/hera-biotech-inc-1831293) $1.7 million · Sep 23, 2026
- [Kayak Therapeutics, Inc.](https://specstream.ai/data/form-d/company/kayak-therapeutics-inc-2088831) $25 million · Aug 21, 2026
- [InnovoTEX Inc.](https://specstream.ai/data/form-d/company/innovotex-inc-1971887) $2.7 million · Aug 18, 2026

[Every Form D from the week of Jan 9, 2017](https://specstream.ai/data/form-d/week/2017-01-09) · [All recent filings in Texas](https://specstream.ai/data/form-d/state/texas) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what APOLLO ENDOSURGERY US INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).